Keywords: sitaliptin, ph, ii, trial, results, promising, usa-based

Sitaliptin Ph II trial results promising

Article | 19 September 2005

Print This

USA-based drugmaker Merck & Co has made public the results of Phase II trials of its new investigational type-2 diabetes treatment ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in